Peptide record

TPDB18421

Antibacterial Antiviral standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB18421
Antibacterial Antiviral
Anti-infective peptides
Peptipedia
standard
No
A 21-aa standard-residue multi-activity (Antibacterial and Antiviral) peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
CLGVGSCVDFAGCGYAVVCFW
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C97H138N22O26S4
RNEQHIKMPT
CGV
2156.53
3.10
0
1
11
-1
-1.41
1.510
83.33
Mammalian: 1.2 hour Yeast: >20 hour E.coli: >10 hour
7240
3.36
6
Residue Composition
number
2
A
0
R
0
N
1
D
4
C
0
E
0
Q
4
G
0
H
0
I
1
L
0
K
0
M
2
F
0
P
1
S
0
T
1
W
1
Y
4
V
Amino Acid Distribution
A: 2 R: 0 N: 0 D: 1 C: 4 E: 0 Q: 0 G: 4 H: 0 I: 0 L: 1 K: 0 M: 0 F: 2 P: 0 S: 1 T: 0 W: 1 Y: 1 V: 4
Chemical Descriptors
21 reviewed residue count
C97H138N22O26S4 sequence-only estimate (linear, free termini)
2156.53 sequence-only estimate (linear, free termini)
3.10 sequence-only estimate (linear, free termini)
-1 sequence-only estimate (linear, free termini)
-1.41 sequence-only estimate (linear, free termini)
1.510 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

NA